BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 3:56:00 PM | Browse: 947 | Download: 787
Publication Name World Journal of Clinical Cases
Manuscript ID 8765
Country Italy
Received
2014-01-06 10:58
Peer-Review Started
2014-01-06 20:25
To Make the First Decision
2014-02-13 15:54
Return for Revision
2014-02-17 20:00
Revised
Second Decision
2014-05-08 17:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-08 18:05
Articles in Press
2014-05-23 09:07
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-05-09 22:31
Typeset the Manuscript
2014-06-13 14:02
Publish the Manuscript Online
2014-06-20 19:16
ISSN 2307-8960 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Cabazitaxel in castration resistant prostate cancer with brain metastases: 3 case reports
Manuscript Source Invited Manuscript
All Author List Sabino De Placido, Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro and Giuseppe Di Lorenzo
Funding Agency and Grant Number
Corresponding Author Giuseppe Di Lorenzo, MD, PhD, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Corso Umberto Ⅰ, Napoli 80140, Italy. giuseppedilorenzoncol@hotmail.com
Key Words Cabazitaxel; Brain metastases; Prostate cancer
Core Tip Due to the improvement in terms of survival, the incidence of brain metastases (BMs) has increased in patients with metastatic castration resistant prostatic cancer (mCRPC). Despite the large number of treatments now available, the prognosis of patients with BMs is still poor. First, we demonstrate the efficacy of cabazitaxel on brain mestastases in three CRPC patients and then show its profile of tolerability in combination with whole brain radiotherapy.
Publish Date 2014-06-20 19:16
Citation De Placido S, Rescigno P, Federico P, Buonerba C, Bosso D, Puglia L, Izzo M, Policastro T, Di Lorenzo G. Cabazitaxel in castration resistant prostate cancer with brain metastases: 3 case reports. World J Clin Cases 2014; 2(6): 228-231
URL http://www.wjgnet.com/2307-8960/full/v2/i6/228.htm
DOI http://dx.doi.org/10.12998/wjcc.v2.i6.228
Full Article (PDF) WJCC-2-228.pdf
Full Article (Word) WJCC-2-228.doc
Manuscript File 8765-Review.docx
Answering Reviewers 8765-Answering reviewers.pdf
Copyright License Agreement 8765-Copyright assignment.pdf
Peer-review Report 8765-Peer review(s).pdf
Scientific Editor Work List 8765-Scientific editor work list.pdf